Anticoagulant therapy for venous thromboembolism
- 1 April 1978
- journal article
- research article
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 63 (4) , 157-164
- https://doi.org/10.1080/00325481.1978.11714815
Abstract
Many questions about anticoagulant therapy, such as whether heparin preparations differ in effectiveness, the best method of heparin administration, and optimum duration of therapy, are still unanswered. However, extensive experimental and clinical experience has led to a closer consensus about some aspects of therapy, and morbidity and mortality associated with venous thromboembolism have been reduced.Keywords
This publication has 22 references indexed in Scilit:
- Letter: Heparin and ristocetin-reduced platelet aggregation.BMJ, 1975
- Heparin ActionCirculation, 1974
- Heparin therapy: A simpler test of controlJournal of Clinical Pathology, 1974
- HEPARIN FROM DIFFERENT SOURCESThe Lancet, 1972
- The Platelet Aggregating Effect of Eight Commercial HeparinsScandinavian Journal of Haematology, 1972
- THE KINETICS OF HEPARIN*Annals of the New York Academy of Sciences, 1971
- Assessment of Anticoagulant Treatment of Venous ThromboembolismAnnals of Surgery, 1969
- Studies on Coumarin Anticoagulant DrugsCirculation, 1968
- Heterogeneity of HeparinBritish Journal of Haematology, 1966
- EVIDENCE AGAINST "REBOUND" THROMBOSIS AFTER STOPPING ORAL ANTICOAGULANT DRUGSThe Lancet, 1963